INR 20.96
(-4.86%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5275.00 INR | 100.65% |
2022 | 2629.00 INR | -47.61% |
2021 | 5018.00 INR | 23.09% |
2020 | 4076.74 INR | 23.66% |
2019 | 3296.85 INR | 74.59% |
2018 | 1888.35 INR | 305.82% |
2017 | 465.31 INR | 2.57% |
2016 | 453.65 INR | -8.15% |
2015 | 493.91 INR | -75.19% |
2014 | 1990.60 INR | -94.91% |
2013 | 39.09 Thousand INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3683.80 INR | -30.16% |
2023 Q4 | 5274.90 INR | 0.0% |
2023 FY | 5274.90 INR | 100.64% |
2023 Q1 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 2629.00 INR | 0.0% |
2022 Q2 | 6672.00 INR | 0.0% |
2021 Q2 | 4938.00 INR | 0.0% |
2021 Q4 | 5018.00 INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 Q4 | 4076.74 INR | 0.0% |
2020 Q2 | 3899.00 INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 3296.85 INR | 0.0% |
2019 Q2 | 2471.00 INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q3 | - INR | -100.0% |
2018 Q4 | 1888.35 INR | 0.0% |
2018 Q2 | 1834.00 INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 551.00 INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 465.31 INR | 0.0% |
2016 Q2 | 940.00 INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 453.65 INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q4 | 493.91 INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 2341.00 INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | 1990.60 INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 Q2 | 41 Thousand INR | 0.0% |
2013 Q2 | 45.53 Thousand INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 39.09 Thousand INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.36 Billion INR | 100.0% |
Biocon Limited | 307.95 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 2.13 Billion INR | 100.0% |
Concord Biotech Limited | 1.74 Billion INR | 100.0% |
Dishman Carbogen Amcis Limited | 39.53 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 2.62 Billion INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | 7.91 Million INR | 99.933% |
Lyka Labs Limited | 884.58 Million INR | 99.999% |
Panacea Biotec Limited | 4.02 Billion INR | 100.0% |
SAMSRITA LABS LIMITED | 32.93 Million INR | 99.984% |
SMS Lifesciences India Limited | 1.96 Billion INR | 100.0% |
Supriya Lifescience Limited | 1.05 Billion INR | 100.0% |
Syngene International Limited | 18.93 Billion INR | 100.0% |
TAKE Solutions Limited | 969.78 Million INR | 99.999% |
Titan Biotech Limited | 231.28 Million INR | 99.998% |
Transgene Biotek Limited | 393.11 Million INR | 99.999% |
Vanta Bioscience Limited | 724.23 Million INR | 99.999% |